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Abstract
Survivorship care plans (SCPs) are intended to educate survivors and providers about survivors’ 
transition from cancer treatment to follow-up care. Using a survey of 23 cancer programs in the 
South Atlantic United States, we (1) describe the prevalence and barriers to SCP use and (2) assess 
relationships between SCP use and (a) barriers and (b) cancer program characteristics. Most 
cancer programs (86%) reported some SCP use; however, less than a quarter of cancer programs’ 
providers had ever used an SCP. The majority (61%) began using SCPs because of professional 
societies’ recommendations. Key barriers to SCP use were insufficient organizational resources 
(75%) and systems for SCP use. We found patterns in SCP use across location, program type and 
professional society membership. Most cancer programs have adopted SCPs, but use remains 
inconsistent. Efforts to promote SCP use should address barriers, particularly in cancer programs 
that are susceptible to barriers to SCP use.
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Introduction
The transition from cancer treatment to follow-up care with primary care providers (PCPs) 
can be difficult for the nearly 14 million cancer survivors in the United States [1]. Survivors 
have unique physical, psychological, social, and spiritual health needs. Optimal survivorship 
care includes (1) prevention and detection of new cancers; (2) surveillance for cancer spread 
or recurrence; (3) intervention for consequences of cancer and its treatment; and (4) 
coordination between specialists and primary care providers to ensure that all of the 
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survivor’s health needs are met [2]. Optimal care may be compromised by PCPs’ and 
oncologists’ conflicting perspectives on their roles in survivorship care. Conflicting 
perspectives among PCPs and oncologists may result in the duplication or omission of 
prevention, detection, surveillance, or treatment services [3]. Survivors often feel poorly 
educated regarding psychological, social and sexual health issues [4] and their risk for 
recurrence [5], and they are often dissatisfied with care following cancer treatment [6].
To mitigate these concerns, the Institute of Medicine (IOM) recommended survivorship care 
plans (SCPs) as instruments to educate survivors and providers regarding the type of cancer, 
treatment and services received, and timing and content of recommended follow-up care [2]. 
Many professional societies now require cancer programs to use SCPs (i.e., develop and 
deliver to survivors and PCPs) [7]; however, barriers may impede cancer programs’ SCP use 
[8].
Empirical evidence of the prevalence and barriers to SCP use is limited. Estimates of SCP 
use prevalence are often tangential to primary research findings, and are from a small subset 
of cancer programs [8, 9], a single state [10], or a very small number of cancer programs 
[11-13]. Existing estimates provide limited information regarding the characteristics of 
cancer programs that use SCPs, such as their location, annual incident cancers, program 
type, or membership in professional societies. Evidence of barriers to SCP use often relates 
to the substantial resources required for SCP use [8, 9, 12]. The extent to which SCP use is 
impeded by other barriers, such as lack of readiness, management support, or a positive 
climate for change, remains unclear.
We address these gaps in the literature by assessing the prevalence of SCP use using a 
survey of cancer programs with a wide range of characteristics including location, annual 
incident cancers, professional society memberships, and program type; assessing a wide 
range of barriers to SCP use, such as lack of readiness, management support, or climate for 
change; and assessing relationships between SCP use and (1) barriers and (2) cancer 
program characteristics. Understanding patterns in prevalence and barriers to SCP use may 
improve efforts of quality improvement organizations and professional societies to educate 
providers regarding the use of SCPs.
Methods
Overview
Our study sample consisted of employees with knowledge of SCP use in South Atlantic 
Division American Cancer Society member programs. These programs had attributes that 
made them an attractive study sample: The second author (DM) had a relationship with the 
South Atlantic Division of American Cancer Society that made the organization amenable to 
encouraging member programs to participate, and they represented a wide range of annual 
incident cancers, program types, and professional society memberships.
A team of experts in survivorship, dissemination and implementation of innovations in 
cancer care, and survey methodology developed the survey. It was based on a review of the 
IOM report [2] and scientific literature. The survey was refined based on a cognitive 
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interview with an employee with knowledge of survivorship care plan use in a cancer 
program not included in the final study sample. Survey items were phrased to elicit 
responses regarding SCP use any time in their cancer program’s history. The final survey 
consisted of 12 items measuring the prevalence and barriers to SCP use (see Table 1).
In August 2011, on behalf of the first author, the South Atlantic Division of the American 
Cancer Society invited member cancer programs (n = 71) to participate in the study. To 
protect the privacy of member cancer programs, the South Atlantic Division of the 
American Cancer Society provided to the first author contact information only for 
employees with knowledge of survivorship care plan use in their cancer program who 
agreed to participate in the study (n = 26; 36.6% of eligible cancer programs). In September 
2011, one employee from each cancer program was invited via email to respond to an online 
version of the survey (Qualtrics Labs, Inc.). Two weeks later, a paper version of the survey 
was sent via first class mail to employees who did not respond to the email invitation. The 
following week, a postcard was sent via first class mail to employees who received the paper 
version of the survey, thanking those who responded to the survey and encouraging those 
who had not yet responded to do so. Finally, the first author contacted non-respondents by 
phone, encouraging them to respond to the survey. Employees in 23 cancer programs 
responded to the survey, for a response rate of 88% of those contacted.
To compare the characteristics of responding cancer programs to other cancer programs the 
South Atlantic United States, and to assess the relationship between SCP use and cancer 
program characteristics, we gathered information regarding cancer programs’ location, 
annual incident cancers, and American College of Surgeons-designated program type, and 
professional society membership. Cancer programs’ location, annual incident cancers, and 
American College of Surgeons-designated program type were obtained from the American 
College of Surgeons website [14]. Cancer programs’ membership in the following 
professional societies was obtained from professional societies’ websites: Association of 
Community Cancer Centers [15]; American Hospital Association [16]; American Society 
for Clinical Oncology [14]; and Commission on Cancer [17]. The institutional review board 
at the University of North Carolina at Chapel Hill deemed the study exempt from human 
subjects review.
Variable descriptions
Survey items and response options are listed in Table 1. We defined an SCP as a written 
document that often, but not always, includes the following information regarding care after 
cancer treatment is complete: surveillance; preventive care; wellness behaviors; and 
symptoms to report. To measure prevalence of SCP use, we asked respondents whether or 
not anyone in their cancer program had ever used an SCP. Secondary measures of SCP use 
included the percentage of providers who used SCPs (defined as physicians, physician 
assistants, nurse practitioners, and nurses); the percentage of survivors for whom SCPs were 
used; and the percentages of survivors and PCPs to whom SCPs were delivered.
To measure barriers to SCP use in cancer programs in which SCPs were not used, we asked 
respondents why SCPs were not used. In cancer programs in which SCPs were used, we 
asked about factors that made it difficult to use SCPs. Respondents also had the opportunity 
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to provide open-ended responses regarding barriers to SCP use. To understand the impetus 
to use SCPs, we asked respondents why SCPs were used in their cancer programs.
Cancer programs’ location was captured at the state level. We defined annual incident 
cancers as the cancer program’s unduplicated number of cancer patients in 2011. American 
College of Surgeons-designated program types included the following: Affiliate hospital 
cancer program; community hospital cancer program; community hospital comprehensive 
cancer program; freestanding cancer center program; hospital associate cancer program; 
integrated cancer program; National Cancer Institute-designated comprehensive cancer 
program; National Cancer Institute-designated network; network cancer program; pediatric 
cancer program; pediatric cancer program component; teaching hospital cancer program; 
and Veterans Affairs cancer program. Cancer programs were considered a member of one of 
the following professional societies if they were listed on the member list website: 
Association of Community Cancer Centers [15]; American Hospital Association [16]; 
American Society for Clinical Oncology [14]; Commission on Cancer [17].
Analysis
To describe the prevalence and barriers to SCP use, we report response frequencies and 
percentages. To compare (1) respondents to other South Atlantic US cancer programs and 
(2) cancer programs that used SCPs to those that did not use SCPs, we used t-tests for 
continuous independent variables (e.g., annual incident cancers) and chi-square statistics for 
categorical independent variables (e.g., program type). To assess variation in the percentage 
of providers who used SCPs and the percentage of survivors for whom SCPs were 
developed, we used t-tests for binary independent variables (i.e., barriers to SCP use, 
professional society membership) and correlations for continuous independent variables 
(e.g., annual incident cancers). Relationships between variables were considered significant 
at the p<.05 level. The unit of analysis was the cancer program. Analyses were conducted 
using Stata 12 (Stata Corp., College Station, TX).
Results
Respondents’ cancer programs had more annual incident cancers than other South Atlantic 
US cancer programs (p<.001). Respondents underrepresented community hospital cancer 
programs (p=.01) and National Cancer Institute-designated comprehensive cancer programs 
(p=.03); they overrepresented teaching hospital cancer programs (p<.0001). Respondents 
were more likely to belong to the Association of Community Cancer Centers (p=.04) and 
Commission on Cancer (p=.02) than other South Atlantic US cancer programs. There were 
no other differences between respondents and other South Atlantic US cancer programs.
Of the 23 respondents, seven were registered nurses (31.8%); six were administrators, such 
as service line directors (27.3%); three were nurse practitioners (13.6%); two were 
physicians (9.1%); two were PhDs (9.1%); and two were social workers (9.1%). 
Respondents reported an average of 1859 annual incident cancers (range: 1129-3248). 
Cancer program types included community hospital comprehensive cancer programs 
(52.4%), NCI-designated comprehensive cancer programs (9.5%), and teaching hospital 
cancer programs (38.1%). Respondents’ cancer programs participated in professional 
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societies including the American Hospital Association (13.6%), Association of Community 
Cancer Centers (68.2%), and Commission on Cancer (95.5%).
Prevalence of SCP use
The majority (86%) of respondents reported that someone in their cancer program had used 
SCPs at least once (see Table 1). However, most respondents (76%) indicated that less than 
a quarter of providers in their cancer programs had ever used an SCP. All respondents 
indicated that SCPs were used for fewer than half of survivors. In most cancer programs, 
SCPs rarely reached their intended audience: Most respondents (62%) reported that SCPs 
were delivered to 50% or fewer of survivors for whom SCPs were developed; half (50%) of 
respondents reported that SCPs were delivered to 25% or fewer of survivors’ PCPs.
Barriers to SCP use
Most (61%) respondents reported that cancer programs began using SCPs because of 
professional societies’ recommendations (see Table 1). Among all respondents, the most 
frequently reported barriers to SCP use included: insufficient organizational resources for 
using SCPs, such as time, staff, money and training (75%), and the fact that some 
professional societies do not yet require SCP use for accreditation (62%). Among 
respondents who indicated an “other” barrier to SCP use, open-ended responses often 
referred to lack of systems to facilitate SCP use. For example, one respondent cited as a 
barrier to SCP use lack of “electronic [SCPs] that populate from…[electronic medical 
records].” Another cited lack of “systematic referral to [a] survivorship nurse.”
Relationships between SCP use and (1) barriers and (2) cancer program characteristics
We found no relationship between SCP use and barriers: Barriers did not differ between 
cancer programs reporting no SCP use and cancer programs reporting some SCP use. We 
found no relationship between barriers to SCP use and the percentage of providers using 
SCPs or the percentage of survivors to whom SCPs were delivered.
Cancer programs reporting no SCP use and cancer programs reporting some SCP use 
differed only with regard to location: Cancer programs reporting no SCP use were located in 
a single state (p=.001). Although differences from cancer programs reporting some SCP use 
were not statistically significant, cancer programs reporting no SCP use were all teaching 
hospitals, and none was a member of the American Hospital Association. We found no 
relationship between cancer program characteristics and the percentage of providers using 
SCPs or the percentage of survivors to whom SCPs were delivered.
Discussion
This study’s objective was to describe the prevalence and barriers to the use of SCPs, an 
instrument intended to educate survivors and patients regarding survivors’ transition from 
cancer treatment to follow-up care, and to assess relationships between SCP use and (1) 
barriers and (2) cancer program characteristics. Results indicate that most cancer programs 
have adopted SCPs, but in most cancer programs less than a quarter of providers have ever 
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used an SCP. This is consistent with previous estimates of SCP use, which range from 14 to 
43 percent [9-11].
Also consistent with previous studies, we found that when SCPs are developed, they are 
often not delivered to survivors or PCPs [10, 18]. There are several possible explanations for 
this finding. First, respondents may not have known how frequently SCPs were delivered to 
survivors or PCPs. This explanation is unlikely, however, because no respondent selected 
the “Don’t know” response option (Table 1). And if respondents were reluctant to admit not 
knowing how frequently SCPs were delivered to survivors or PCPs, social desirability bias 
would likely have inflated estimates; our low estimates of SCP delivery suggest that this was 
not the case. Second, our findings reflect a single point in time, relatively soon after 
professional societies began to require SCP use. At the time of our survey, respondents’ 
cancer programs may not have implemented plans to deliver SCPs. A survey at a later date 
might have found more widespread SCP delivery.
Third, cancer programs may develop SCPs to meet minimum standards for compliance with 
professional societies’ SCP use requirements. Cancer programs using SCPs for the sole 
purpose of complying with professional societies’ requirements may be disinclined to make 
the organizational changes required to deliver SCPs to survivors and PCPs. Indeed, our 
results suggest that professional societies’ requirements compel cancer programs to use 
SCPs; insufficient organizational resources and systems are barriers to SCP use. These 
results are consistent with other studies of barriers to SCP use. Dulko and colleagues (2012) 
found that a substantial barrier to SCP use was the time necessary to obtain the information 
required to create an SCP [12]. Chubak and colleagues (2012) found that lack of staff 
impeded SCP use. Others have cited as barriers lack of templates, time to complete SCP, 
training and reimbursement for SCP use [10, 11, 19, 20].
Patterns in SCP use suggest that some cancer programs may be more susceptible to barriers 
to SCP use. Each of the cancer programs reporting no SCP use was a teaching hospital. 
Teaching hospitals may have fewer resources available to commit to using SCPs than other 
cancer program types [21]. None of these programs was a member of the American Hospital 
Association. As such, they did not participate in the American Hospital Association’s 
initiatives to improve hospital quality and organizational performance; these initiatives may 
have promoted SCP use [22].
Our study has several limitations. First, survey items were not validated. This measurement 
bias emphasizes the need for the development of measures in dissemination and 
implementation research [23]. Validated measures will promote strong research in a rapidly 
developing field. Second, social desirability bias may have caused respondents to over-
report SCP use. Third, the majority of respondents were registered nurses and 
administrators. Their perspectives on SCP use may differ from the perspectives of other 
cancer program employees, such as medical directors, physicians, and other providers. 
Fourth, our sample size limited our ability to draw conclusions regarding relationships 
between SCP use and (1) barriers and (2) cancer program characteristics. Future studies 
should use larger samples. Fifth, our study results have limited generalizability. Respondents 
who agreed to participate in the study may have been more likely to respond if their cancer 
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programs used SCPs. Further, responding cancer programs were not representative of other 
South Atlantic US cancer programs in terms of annual incident cancers, some program 
types, and membership in some professional societies; ostensibly, responding cancer 
programs were not representative of US cancer programs. Future studies should use a 
nationally representative sample of cancer programs.
Despite these limitations, our findings have implications for educating survivors and 
providers about survivors’ transition from cancer treatment to follow-up care. Professional 
societies’ efforts to educate providers regarding the use of SCPs may have a stronger 
influence when complemented by efforts to address barriers to SCP use. For example, 
professional societies may consider publicizing methods of SCP use that minimize the 
burden on organizational resources and maximize the use of organizational systems to 
facilitate SCP use. In particular, these efforts should target cancer programs that are 
susceptible to barriers to SCP use, such as those in under-resourced teaching hospitals.
Additional research is needed to better understand patterns of SCP use across professional 
societies, SCP templates (e.g., Journey Forward), and tumor groups. For example, if SCPs 
have been used most widely with breast cancer survivors, efforts to educate providers 
regarding SCP use may be most successful if they are focused on breast cancer care 
providers. Before this research is conducted, however, several methodological concerns 
must be addressed. First, the definition of “SCP” must be clarified. Currently, several, often 
conflicting, definitions exist. Second, reliable and valid measures of SCP use and its 
determinants must be developed. For example, is including SCPs in health records sufficient 
to educate survivors and providers regarding survivors’ transition from cancer treatment to 
follow-up care, or must SCPs be delivered to survivors during a clinical visit and sent to 
providers to qualify as effective SCP use? Third, optimal survey respondents should be 
identified. Do medical directors have intimate enough knowledge of SCP use, or are perhaps 
nurse managers more appropriate respondents? Addressing these methodological concerns 
will bring us closer to understanding patterns of SCP use; understanding patterns of SCP use 
will help to target efforts to educate providers regarding SCP use and, in turn, the potential 
for survivors to benefit from SCPs as intended.
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Table 1
Survey item response options and frequencies (n = 23)
# Item Response options Frequency (%)
1 Has anyone, including
you, in your cancer







in your cancer program






3 For approximately what
percentage of all
survivors in your cancer









4 For approximately what
percentage of these
survivors for whom SCPs


















6 Why did providers in
your cancer program
begin using SCPs?
(Check all that apply.)
American College of Surgeons (ACS) guidelines 61
American Society for Clinical Oncology (ASCO) guidelines 61
Institute of Medicine’s (IOM) From Cancer Patient to Cancer
  Survivor
56
National Comprehensive Cancer Network (NCCN) evidence 44
Other ____________________________________ 44
Association of Community Cancer Center (ACCC) guidelines 22
Advice from colleague 17
National Coalition for Cancer Survivorship (NCCS)/Lance
  Armstrong Foundation guidelines
17




The cancer program is not ready to make the changes necessary 33
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# Item Response options Frequency (%)
assistants, nurse
practitioners, nurses) in
your cancer program use
SCPs? (Check all that
apply.)
a
  to use survivorship care plans.
Using SCPs is not expected. 33
Providers do not know about SCPs. 33
Providers do not know enough about SCPs to use them. 33
No one champions using SCPs. 33
Resources aren’t sufficient to use SCPs (e.g., time, staff, money,
  training).
33
Middle managers (e.g., department supervisor, nurse manager)
  don’t support using SCPs.
0
Using SCPs is not rewarded. 0
Using SCPs is not supported. 0
Providers don’t feel that SCPs are an effective tool for easing the
  transition from treatment to survivorship care.
0
Top managers (i.e., CEO, CFO, COO, Medical Director) don’t
  support using SCPs.
0
8 In your opinion, when
providers have been
able to use SCPs, which
of the following have
made it harder to use
SCPs in your cancer
program?
Resources aren’t sufficient to use SCPs (e.g., time, staff, money,
  training).
76
Using SCPs is not rewarded. 29
No one champions using SCPs. 29
Providers don’t feel that SCPs are an effective tool for easing the
  transition from treatment to survivorship care.
12
The cancer program is not ready to make the changes necessary
  to use survivorship care plans.
12
Other _______________________________________________ 3
Using SCPs is not expected. 5
Middle managers (e.g., department supervisor, nurse manager)
  don’t support using SCPs.
0
Using SCPs is not supported. 0
Top managers (i.e., CEO, CFO, COO, Medical Director) don’t
  support using SCPs.
0
a
For those who responded “no” to item 1.
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